|
|
|
|
|
Focus Groups |
Biopharmaceutics and Oral Drug Delivery |
[Group Library]
(members only) |
|
Scope
The focus group
will cover the promotion of scientific education and training in the field of
biopharmaceutics from an industrial and academic perspective.
Aims
To support the
on-going education of both academic and industrial scientists involved in the
area of biopharmaceutics. To establish a comprehensive information source. To
organise a symposium and / or workshop each year and to contribute to the BPC
scientific programme.
Biopharmaceutics can
be defined as the study of how the physicochemical properties of a drug, the
dosage form and the route of administration affect the rate and extent of drug
absorption. It is a rapidly growing area within
the Pharmaceutical Industry. In the main, biopharmaceutical science and
technology is applied to projects in late discovery and early development. The
generation of biopharmaceutical information at this stage is used to identify
risks to the continued progression of a project and to critically appraise
development potential. The objectives are a reduction in project failures,
caused by poor biopharmaceutical properties, and a greater understanding of the
applicability and implications of progressing specialised drug delivery
strategies. An initiative to form a focus Group for the discussion of
Biopharmaceutical issues within the Pharmaceutical Industry was started at the
beginning of 1999. All of the major Pharmaceutical Companies located in the UK
were represented. A number of meetings have taken place; focussing on
identifying objectives and possibilities for progressing these. Two main
objectives were defined:
1. The promotion of scientific education and training in the field of
biopharmaceutics
• Organisation of one day meetings for industry / students / graduates
• Collation of major references in area
• Construction of a web page containing relevant information and links
• Input into training materials e.g. PIAT module
2. Promote a focus on biopharmaceutical issues at scientific meetings and
conferences
• Influence larger organisations
• Joint funded research
|
|
|
|
|
|
|